<DOC>
	<DOCNO>NCT01326780</DOCNO>
	<brief_summary>A study determine three different dose new acne treatment safe well reduce facial acne treatment without active ingredient .</brief_summary>
	<brief_title>A Study New Drug Treatment Acne</brief_title>
	<detailed_description>Approximately 400 male female subject moderate facial acne vulgaris enrol randomize , multi-center study . Following satisfaction entry criterion screen procedure , subject randomize either 1.2 % , 2.4 % , 3.6 % facial cream ( JNJ 10229570-AAA ) color-matched vehicle . Subjects apply study medication daily face 12 week . Safety monitor throughout study duration . Efficacy assess facial lesion count investigator global evaluation acne severity Baseline Weeks 2 , 4 , 6 , 8 , 10 , 12 . Approximately 50 subject one investigational site also serums collect Weeks 6 12 evaluation multiple dose pharmacokinetics JNJ 10229570-AAA cream .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>12 year age old , moderate facial acne vulgaris define protocol If female childbearing potential , must take pregnancy test negative result Females childbearing potential must also agree use adequate method birth control , would include : systemic birth control ( Subjects must take type birth control least 3 month prior enter study must change type birth control study ) Condom spermicide IUD . Females hysterectomy , bilateral oophorectomy bilateral tubal ligation require use additional birth control method Known sensitivity ingredient study medication More 3 nodulocystic acne lesion Use acne treatment , therapy medication within protocolspecified timeframes Presence skin condition , disease , medical condition ( per protocol opinion investigator ) may require concurrent therapy , interfere evaluation study medication , compromise subject safety Excessive facial hair may interfere application medication and/or evaluation</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Acne</keyword>
	<keyword>Irritation</keyword>
	<keyword>Safety</keyword>
	<keyword>Sebum</keyword>
</DOC>